Lensar (LNSR) Return on Capital Employed Growth (3y) (2023 - 2026)
Lensar (LNSR) Return on Capital Employed Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 108.10 Bn | 98.88 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 67.99 Bn | 66.53 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | -846.00 |
| 6 | Dexcom | 28.26 Bn | 27.15 Bn | 750.30 Mn | 1,318.00 |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | -247.00 |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.74 Bn | 20.62 Bn | 2.07 Bn | - |
| 10 | Lensar | 65.43 Mn | 54.33 Mn | 6.38 Mn | 823.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 823.00 |
| Dec 31, 2025 | -3,531.00 |
| Sep 30, 2025 | -1,484.00 |
| Jun 30, 2025 | 1,366.00 |
| Mar 31, 2025 | 595.00 |
| Dec 31, 2024 | 1,186.00 |
| Sep 30, 2024 | 1,162.00 |
| Jun 30, 2024 | 778.00 |
| Mar 31, 2024 | 1,060.00 |
| Dec 31, 2023 | 502.00 |